IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAH1. A total of 22 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $242,003 | -3.6% | 249,000 | +1.2% | 0.00% | – |
| Q2 2023 | $251,141 | +1.9% | 246,000 | 0.0% | 0.00% | – |
| Q1 2023 | $246,509 | -53.6% | 246,000 | -53.0% | 0.00% | – |
| Q3 2022 | $531,000 | -6.0% | 523,000 | 0.0% | 0.00% | – |
| Q2 2022 | $565,000 | -8.3% | 523,000 | 0.0% | 0.00% | – |
| Q1 2022 | $616,000 | +3.7% | 523,000 | 0.0% | 0.00% | – |
| Q4 2021 | $594,000 | -39.7% | 523,000 | -36.5% | 0.00% | -100.0% |
| Q3 2021 | $985,000 | +0.6% | 823,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $979,000 | +181.3% | 823,000 | +167.2% | 0.00% | – |
| Q1 2021 | $348,000 | – | 308,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 69,285,732 | $54,302,494 | 2.70% |
| CAMDEN ASSET MANAGEMENT L P /CA | 50,071,000 | $48,664,005 | 1.81% |
| Boussard & Gavaudan Investment Management LLP | 6,577 | $6,483,091 | 0.76% |
| READYSTATE ASSET MANAGEMENT LP | 12,000,000 | $11,722,800 | 0.59% |
| BRAIDWELL LP | 15,500,000 | $15,141,950 | 0.48% |
| WOLVERINE ASSET MANAGEMENT LLC | 39,174,000 | $38,348,717 | 0.43% |
| CSS LLC/IL | 5,500,000 | $5,379,280 | 0.35% |
| SHENKMAN CAPITAL MANAGEMENT INC | 3,239,000 | $3,239,825 | 0.24% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 15,174,000 | $14,823,481 | 0.07% |
| Calamos Advisors LLC | 9,500,000 | $9,281,500 | 0.05% |